Treatment in patients with acute myeloid leukemia/high-risk myelodysplastic syndrome with hypomethylating agents: Day-hospital management compared to home care setting.

Giulio TrapèGioia De AngelisMarco MorucciMichela TarnaniCinzia De GregorisAmbra Di VeroliValentina PanichiGiuseppe TopiniLoredana BassiRaffaella IsidoriMonica PoscenteVincenza InnocentiElisa Emanueli CippitelliRoberta TalucciSilvia BertelliAlessandra CrocicchiaAnnalisa LippiGiulia PezzutiMichela FuschinoRaffaella RandiCristina MastiniSilvia CiambellaGloria PessinaMarco MontanaroRoberto Latagliata

Published in: European journal of haematology (2023)

Home care management of HMA is feasible and effective, with results similar to standard DH setting: this approach is thus adequate to offer active therapies in frail patients with AML/HR-MDS considered up to now ineligible.

Keyphrases

acute myeloid leukemia
allogeneic hematopoietic stem cell transplantation
healthcare
adverse drug
smoking cessation